Detalhe da pesquisa
1.
MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patients.
Cancer Immunol Immunother
; 60(6): 829-37, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21387109
2.
Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma.
Lung Cancer
; 77(2): 312-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22498111
3.
Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study.
Clin Cancer Res
; 16(22): 5539-47, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20881001
4.
Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial.
J Immunother
; 32(7): 765-72, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19561532